Global Oncology Drugs Market Growth 2020-2025

January 2020 | 162 pages | ID: G789FC81D8CEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

According to this study, over the next five years the Oncology Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Oncology Drugs business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Oncology Drugs market by type, application, key manufacturers and key regions and countries.

This study considers the Oncology Drugs value and volume generated from the sales of the following segments:

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

• Antimetabolite
• Alkaloid drugs
• Hormone
• Targeted drug
• Platinum-based drugs
• Others

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

• Blood Cancer
• Breast Cancer
• Gastrointestinal Cancer
• Prostate Cancer
• Respiratory/Lung Cancer
• Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

• Roche
• Lunan
• HENGRUI
• QILU
• Sanofi
• AstraZeneca
• Novartis
• HANSOH
• GuiZhou YiBai
• LUYE
• Eli Lilly and Company

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Oncology Drugs consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
• To understand the structure of Oncology Drugs market by identifying its various subsegments.
• Focuses on the key global Oncology Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Oncology Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Oncology Drugs submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Oncology Drugs Consumption 2015-2025
  2.1.2 Oncology Drugs Consumption CAGR by Region
2.2 Oncology Drugs Segment by Type
  2.2.1 Antimetabolite
  2.2.2 Alkaloid drugs
  2.2.3 Hormone
  2.2.4 Targeted drug
  2.2.5 Platinum-based drugs
  2.2.6 Others
2.3 Oncology Drugs Consumption by Type
  2.3.1 Global Oncology Drugs Consumption Market Share by Type (2015-2020)
  2.3.2 Global Oncology Drugs Revenue and Market Share by Type (2015-2020)
  2.3.3 Global Oncology Drugs Sale Price by Type (2015-2020)
2.4 Oncology Drugs Segment by Application
  2.4.1 Blood Cancer
  2.4.2 Breast Cancer
  2.4.3 Gastrointestinal Cancer
  2.4.4 Prostate Cancer
  2.4.5 Respiratory/Lung Cancer
  2.4.6 Others
2.5 Oncology Drugs Consumption by Application
  2.5.1 Global Oncology Drugs Consumption Market Share by Type (2015-2020)
  2.5.2 Global Oncology Drugs Value and Market Share by Type (2015-2020)
  2.5.3 Global Oncology Drugs Sale Price by Type (2015-2020)

3 GLOBAL ONCOLOGY DRUGS BY COMPANY

3.1 Global Oncology Drugs Sales Market Share by Company
  3.1.1 Global Oncology Drugs Sales by Company (2018-2020)
  3.1.2 Global Oncology Drugs Sales Market Share by Company (2018-2020)
3.2 Global Oncology Drugs Revenue Market Share by Company
  3.2.1 Global Oncology Drugs Revenue by Company (2018-2020)
  3.2.2 Global Oncology Drugs Revenue Market Share by Company (2018-2020)
3.3 Global Oncology Drugs Sale Price by Company
3.4 Global Oncology Drugs Manufacturing Base Distribution, Sales Area, Type by Company
  3.4.1 Global Oncology Drugs Manufacturing Base Distribution and Sales Area by Company
  3.4.2 Players Oncology Drugs Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 ONCOLOGY DRUGS BY REGIONS

4.1 Oncology Drugs by Regions
4.2 Americas Oncology Drugs Consumption Growth
4.3 APAC Oncology Drugs Consumption Growth
4.4 Europe Oncology Drugs Consumption Growth
4.5 Middle East & Africa Oncology Drugs Consumption Growth

5 AMERICAS

5.1 Americas Oncology Drugs Consumption by Countries
  5.1.1 Americas Oncology Drugs Consumption by Countries (2015-2020)
  5.1.2 Americas Oncology Drugs Value by Countries (2015-2020)
5.2 Americas Oncology Drugs Consumption by Type
5.3 Americas Oncology Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Oncology Drugs Consumption by Regions
  6.1.1 APAC Oncology Drugs Consumption by Regions (2015-2020)
  6.1.2 APAC Oncology Drugs Value by Regions (2015-2020)
6.2 APAC Oncology Drugs Consumption by Type
6.3 APAC Oncology Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 EUROPE

7.1 Europe Oncology Drugs by Countries
  7.1.1 Europe Oncology Drugs Consumption by Countries (2015-2020)
  7.1.2 Europe Oncology Drugs Value by Countries (2015-2020)
7.2 Europe Oncology Drugs Consumption by Type
7.3 Europe Oncology Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Oncology Drugs by Countries
  8.1.1 Middle East & Africa Oncology Drugs Consumption by Countries (2015-2020)
  8.1.2 Middle East & Africa Oncology Drugs Value by Countries (2015-2020)
8.2 Middle East & Africa Oncology Drugs Consumption by Type
8.3 Middle East & Africa Oncology Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Channels
  10.1.2 Indirect Channels
10.2 Oncology Drugs Distributors
10.3 Oncology Drugs Customer

11 GLOBAL ONCOLOGY DRUGS MARKET FORECAST

11.1 Global Oncology Drugs Consumption Forecast (2021-2025)
11.2 Global Oncology Drugs Forecast by Regions
  11.2.1 Global Oncology Drugs Forecast by Regions (2021-2025)
  11.2.2 Global Oncology Drugs Value Forecast by Regions (2021-2025)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Oncology Drugs Forecast by Type
11.8 Global Oncology Drugs Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Roche
  12.1.1 Company Information
  12.1.2 Oncology Drugs Product Offered
  12.1.3 Roche Oncology Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
  12.1.4 Main Business Overview
  12.1.5 Roche Latest Developments
12.2 Lunan
  12.2.1 Company Information
  12.2.2 Oncology Drugs Product Offered
  12.2.3 Lunan Oncology Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
  12.2.4 Main Business Overview
  12.2.5 Lunan Latest Developments
12.3 HENGRUI
  12.3.1 Company Information
  12.3.2 Oncology Drugs Product Offered
  12.3.3 HENGRUI Oncology Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
  12.3.4 Main Business Overview
  12.3.5 HENGRUI Latest Developments
12.4 QILU
  12.4.1 Company Information
  12.4.2 Oncology Drugs Product Offered
  12.4.3 QILU Oncology Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
  12.4.4 Main Business Overview
  12.4.5 QILU Latest Developments
12.5 Sanofi
  12.5.1 Company Information
  12.5.2 Oncology Drugs Product Offered
  12.5.3 Sanofi Oncology Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
  12.5.4 Main Business Overview
  12.5.5 Sanofi Latest Developments
12.6 AstraZeneca
  12.6.1 Company Information
  12.6.2 Oncology Drugs Product Offered
  12.6.3 AstraZeneca Oncology Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
  12.6.4 Main Business Overview
  12.6.5 AstraZeneca Latest Developments
12.7 Novartis
  12.7.1 Company Information
  12.7.2 Oncology Drugs Product Offered
  12.7.3 Novartis Oncology Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
  12.7.4 Main Business Overview
  12.7.5 Novartis Latest Developments
12.8 HANSOH
  12.8.1 Company Information
  12.8.2 Oncology Drugs Product Offered
  12.8.3 HANSOH Oncology Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
  12.8.4 Main Business Overview
  12.8.5 HANSOH Latest Developments
12.9 GuiZhou YiBai
  12.9.1 Company Information
  12.9.2 Oncology Drugs Product Offered
  12.9.3 GuiZhou YiBai Oncology Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
  12.9.4 Main Business Overview
  12.9.5 GuiZhou YiBai Latest Developments
12.10 LUYE
  12.10.1 Company Information
  12.10.2 Oncology Drugs Product Offered
  12.10.3 LUYE Oncology Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
  12.10.4 Main Business Overview
  12.10.5 LUYE Latest Developments
12.11 Eli Lilly and Company
  12.11.1 Company Information
  12.11.2 Oncology Drugs Product Offered
  12.11.3 Eli Lilly and Company Oncology Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
  12.11.4 Main Business Overview
  12.11.5 Eli Lilly and Company Latest Developments

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Research Methodology
Table 2. Data Source
Table 3. Oncology Drugs Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Antimetabolite
Table 5. Major Players of Alkaloid drugs
Table 6. Major Players of Hormone
Table 7. Major Players of Targeted drug
Table 8. Major Players of Platinum-based drugs
Table 9. Major Players of Others
Table 10. Global Consumption Sales by Type (2015-2020)
Table 11. Global Oncology Drugs Consumption Market Share by Type (2015-2020)
Table 12. Global Oncology Drugs Revenue by Type (2015-2020) ($ million)
Table 13. Global Oncology Drugs Value Market Share by Type (2015-2020) ($ Millions)
Table 14. Global Oncology Drugs Sale Price by Type (2015-2020)
Table 15. Global Consumption Sales by Application (2015-2020)
Table 16. Global Oncology Drugs Consumption Market Share by Application (2015-2020)
Table 17. Global Oncology Drugs Value by Application (2015-2020)
Table 18. Global Oncology Drugs Value Market Share by Application (2015-2020)
Table 19. Global Oncology Drugs Sale Price by Application (2015-2020)
Table 20. Global Oncology Drugs Sales by Company (2017-2019) (BBL)
Table 21. Global Oncology Drugs Sales Market Share by Company (2017-2019)
Table 22. Global Oncology Drugs Revenue by Company (2017-2019) ($ Millions)
Table 23. Global Oncology Drugs Revenue Market Share by Company (2017-2019)
Table 24. Global Oncology Drugs Sale Price by Company (2017-2019)
Table 25. Global Oncology Drugs Manufacturing Base Distribution and Sales Area by Manufacturers
Table 26. Players Oncology Drugs Products Offered
Table 27. Oncology Drugs Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 28. Global Oncology Drugs Consumption by Regions 2015-2020 (BBL)
Table 29. Global Oncology Drugs Consumption Market Share by Regions 2015-2020
Table 30. Global Oncology Drugs Value by Regions 2015-2020 ($ Millions)
Table 31. Global Oncology Drugs Value Market Share by Regions 2015-2020
Table 32. Americas Oncology Drugs Consumption by Countries (2015-2020) (BBL)
Table 33. Americas Oncology Drugs Consumption Market Share by Countries (2015-2020)
Table 34. Americas Oncology Drugs Value by Countries (2015-2020) ($ Millions)
Table 35. Americas Oncology Drugs Value Market Share by Countries (2015-2020)
Table 36. Americas Oncology Drugs Consumption by Type (2015-2020) (BBL)
Table 37. Americas Oncology Drugs Consumption Market Share by Type (2015-2020)
Table 38. Americas Oncology Drugs Consumption by Application (2015-2020) (BBL)
Table 39. Americas Oncology Drugs Consumption Market Share by Application (2015-2020)
Table 40. APAC Oncology Drugs Consumption by Countries (2015-2020) (BBL)
Table 41. APAC Oncology Drugs Consumption Market Share by Countries (2015-2020)
Table 42. APAC Oncology Drugs Value by Regions (2015-2020) ($ Millions)
Table 43. APAC Oncology Drugs Value Market Share by Regions (2015-2020)
Table 44. APAC Oncology Drugs Consumption by Type (2015-2020) (BBL)
Table 45. APAC Oncology Drugs Consumption Market Share by Type (2015-2020)
Table 46. APAC Oncology Drugs Consumption by Application (2015-2020) (BBL)
Table 47. APAC Oncology Drugs Consumption Market Share by Application (2015-2020)
Table 48. Europe Oncology Drugs Consumption by Countries (2015-2020) (BBL)
Table 49. Europe Oncology Drugs Consumption Market Share by Countries (2015-2020)
Table 50. Europe Oncology Drugs Value by Countries (2015-2020) ($ Millions)
Table 51. Europe Oncology Drugs Value Market Share by Countries (2015-2020)
Table 52. Europe Oncology Drugs Consumption by Type (2015-2020) (BBL)
Table 53. Europe Oncology Drugs Consumption Market Share by Type (2015-2020)
Table 54. Europe Oncology Drugs Consumption by Application (2015-2020) (BBL)
Table 55. Europe Oncology Drugs Consumption Market Share by Application (2015-2020)
Table 56. Middle East & Africa Oncology Drugs Consumption by Countries (2015-2020) (BBL)
Table 57. Middle East & Africa Oncology Drugs Consumption Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Oncology Drugs Value by Countries (2015-2020) ($ Millions)
Table 59. Middle East & Africa Oncology Drugs Value Market Share by Countries (2015-2020)
Table 60. Middle East & Africa Oncology Drugs Consumption by Type (2015-2020) (BBL)
Table 61. Middle East & Africa Oncology Drugs Consumption Market Share by Type (2015-2020)
Table 62. Middle East & Africa Oncology Drugs Consumption by Application (2015-2020) (BBL)
Table 63. Middle East & Africa Oncology Drugs Consumption Market Share by Application (2015-2020)
Table 64. Oncology Drugs Distributors List
Table 65. Oncology Drugs Customer List
Table 66. Global Oncology Drugs Consumption Forecast by Countries (2021-2025) (BBL)
Table 67. Global Oncology Drugs Consumption Market Forecast by Regions
Table 68. Global Oncology Drugs Value Forecast by Countries (2021-2025) ($ Millions)
Table 69. Global Oncology Drugs Value Market Share Forecast by Regions
Table 70. Global Oncology Drugs Consumption Forecast by Type (2021-2025) (BBL)
Table 71. Global Oncology Drugs Consumption Market Share Forecast by Type (2021-2025)
Table 72. Global Oncology Drugs Value Forecast by Type (2021-2025) ($ Millions)
Table 73. Global Oncology Drugs Value Market Share Forecast by Type (2021-2025)
Table 74. Global Oncology Drugs Consumption Forecast by Application (2021-2025) (BBL)
Table 75. Global Oncology Drugs Consumption Market Share Forecast by Application (2021-2025)
Table 76. Global Oncology Drugs Value Forecast by Application (2021-2025) ($ Millions)
Table 77. Global Oncology Drugs Value Market Share Forecast by Application (2021-2025)
Table 78. Roche Product Offered
Table 79. Roche Oncology Drugs Sales (BBL), Revenue ($ Million), Price (USD/BBL) and Gross Margin (2018-2020E)
Table 80. Roche Main Business
Table 81. Roche Latest Developments
Table 82. Roche Basic Information, Company Total Revenue (in $ million), Oncology Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Lunan Product Offered
Table 84. Lunan Oncology Drugs Sales (BBL), Revenue ($ Million), Price (USD/BBL) and Gross Margin (2018-2020E)
Table 85. Lunan Main Business
Table 86. Lunan Latest Developments
Table 87. Lunan Basic Information, Company Total Revenue (in $ million), Oncology Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. HENGRUI Product Offered
Table 89. HENGRUI Oncology Drugs Sales (BBL), Revenue ($ Million), Price (USD/BBL) and Gross Margin (2018-2020E)
Table 90. HENGRUI Main Business
Table 91. HENGRUI Latest Developments
Table 92. HENGRUI Basic Information, Company Total Revenue (in $ million), Oncology Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. QILU Product Offered
Table 94. QILU Oncology Drugs Sales (BBL), Revenue ($ Million), Price (USD/BBL) and Gross Margin (2018-2020E)
Table 95. QILU Main Business
Table 96. QILU Latest Developments
Table 97. QILU Basic Information, Company Total Revenue (in $ million), Oncology Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Sanofi Product Offered
Table 99. Sanofi Oncology Drugs Sales (BBL), Revenue ($ Million), Price (USD/BBL) and Gross Margin (2018-2020E)
Table 100. Sanofi Main Business
Table 101. Sanofi Latest Developments
Table 102. Sanofi Basic Information, Company Total Revenue (in $ million), Oncology Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. AstraZeneca Product Offered
Table 104. AstraZeneca Oncology Drugs Sales (BBL), Revenue ($ Million), Price (USD/BBL) and Gross Margin (2018-2020E)
Table 105. AstraZeneca Main Business
Table 106. AstraZeneca Latest Developments
Table 107. AstraZeneca Basic Information, Company Total Revenue (in $ million), Oncology Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Novartis Product Offered
Table 109. Novartis Basic Information, Company Total Revenue (in $ million), Oncology Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. Novartis Main Business
Table 111. Novartis Latest Developments
Table 112. Novartis Oncology Drugs Sales (BBL), Revenue ($ Million), Price (USD/BBL) and Gross Margin (2018-2020E)
Table 113. HANSOH Product Offered
Table 114. HANSOH Oncology Drugs Sales (BBL), Revenue ($ Million), Price (USD/BBL) and Gross Margin (2018-2020E)
Table 115. HANSOH Main Business
Table 116. HANSOH Latest Developments
Table 117. HANSOH Basic Information, Company Total Revenue (in $ million), Oncology Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. GuiZhou YiBai Product Offered
Table 119. GuiZhou YiBai Oncology Drugs Sales (BBL), Revenue ($ Million), Price (USD/BBL) and Gross Margin (2018-2020E)
Table 120. GuiZhou YiBai Main Business
Table 121. GuiZhou YiBai Latest Developments
Table 122. GuiZhou YiBai Basic Information, Company Total Revenue (in $ million), Oncology Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. LUYE Product Offered
Table 124. LUYE Oncology Drugs Sales (BBL), Revenue ($ Million), Price (USD/BBL) and Gross Margin (2018-2020E)
Table 125. LUYE Main Business
Table 126. LUYE Latest Developments
Table 127. LUYE Basic Information, Company Total Revenue (in $ million), Oncology Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. Eli Lilly and Company Product Offered
Table 129. Eli Lilly and Company Oncology Drugs Sales (BBL), Revenue ($ Million), Price (USD/BBL) and Gross Margin (2018-2020E)
Table 130. Eli Lilly and Company Main Business
Table 131. Eli Lilly and Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 132. Eli Lilly and Company Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Oncology Drugs
Figure 2. Oncology Drugs Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Oncology Drugs Consumption Growth Rate 2015-2025 (BBL)
Figure 5. Global Oncology Drugs Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Antimetabolite
Figure 7. Product Picture of Alkaloid drugs
Figure 8. Product Picture of Hormone
Figure 9. Product Picture of Targeted drug
Figure 10. Product Picture of Platinum-based drugs
Figure 11. Product Picture of Others
Figure 12. Global Oncology Drugs Consumption Market Share by Type (2015-2020)
Figure 13. Global Oncology Drugs Value Market Share by Type (2015-2020)
Figure 14. Oncology Drugs Consumed in Blood Cancer
Figure 15. Global Oncology Drugs Market: Blood Cancer (2015-2020) (BBL)
Figure 16. Global Oncology Drugs Market: Blood Cancer (2015-2020) ($ Millions)
Figure 17. Oncology Drugs Consumed in Breast Cancer
Figure 18. Global Oncology Drugs Market: Breast Cancer (2015-2020) (BBL)
Figure 19. Global Oncology Drugs Market: Breast Cancer (2015-2020) ($ Millions)
Figure 20. Oncology Drugs Consumed in Gastrointestinal Cancer
Figure 21. Global Oncology Drugs Market: Gastrointestinal Cancer (2015-2020) (BBL)
Figure 22. Global Oncology Drugs Market: Gastrointestinal Cancer (2015-2020) ($ Millions)
Figure 23. Oncology Drugs Consumed in Prostate Cancer
Figure 24. Global Oncology Drugs Market: Prostate Cancer (2015-2020) (BBL)
Figure 25. Global Oncology Drugs Market: Prostate Cancer (2015-2020) ($ Millions)
Figure 26. Oncology Drugs Consumed in Respiratory/Lung Cancer
Figure 27. Global Oncology Drugs Market: Respiratory/Lung Cancer (2015-2020) (BBL)
Figure 28. Global Oncology Drugs Market: Respiratory/Lung Cancer (2015-2020) ($ Millions)
Figure 29. Oncology Drugs Consumed in Others
Figure 30. Global Oncology Drugs Consumption Market Share by Application (2015-2020)
Figure 31. Global Oncology Drugs Value Market Share by Application (2015-2020)
Figure 32. Global Oncology Drugs Sales Market Share by Company in 2017
Figure 33. Global Oncology Drugs Sales Market Share by Company in 2019
Figure 34. Global Oncology Drugs Revenue Market Share by Company in 2017
Figure 35. Global Oncology Drugs Revenue Market Share by Company in 2019
Figure 36. Global Oncology Drugs Sale Price by Company in 2019
Figure 37. Global Oncology Drugs Consumption Market Share by Regions 2015-2020
Figure 38. Global Oncology Drugs Value Market Share by Regions 2015-2020
Figure 39. Americas Oncology Drugs Consumption 2015-2020 (BBL)
Figure 40. Americas Oncology Drugs Value 2015-2020 ($ Millions)
Figure 41. APAC Oncology Drugs Consumption 2015-2020 (BBL)
Figure 42. APAC Oncology Drugs Value 2015-2020 ($ Millions)
Figure 43. Europe Oncology Drugs Consumption 2015-2020 (BBL)
Figure 44. Europe Oncology Drugs Value 2015-2020 ($ Millions)
Figure 45. Middle East & Africa Oncology Drugs Consumption 2015-2020 (BBL)
Figure 46. Middle East & Africa Oncology Drugs Value 2015-2020 ($ Millions)
Figure 47. Americas Oncology Drugs Consumption Market Share by Countries in 2019
Figure 48. Americas Oncology Drugs Value Market Share by Countries in 2019
Figure 49. Americas Oncology Drugs Consumption Market Share by Type in 2019
Figure 50. Americas Oncology Drugs Consumption Market Share by Application in 2019
Figure 51. United States Oncology Drugs Consumption Growth 2015-2020 (BBL)
Figure 52. United States Oncology Drugs Value Growth 2015-2020 ($ Millions)
Figure 53. Canada Oncology Drugs Consumption Growth 2015-2020 (BBL)
Figure 54. Canada Oncology Drugs Value Growth 2015-2020 ($ Millions)
Figure 55. Mexico Oncology Drugs Consumption Growth 2015-2020 (BBL)
Figure 56. Mexico Oncology Drugs Value Growth 2015-2020 ($ Millions)
Figure 57. APAC Oncology Drugs Consumption Market Share by Countries in 2019
Figure 58. APAC Oncology Drugs Value Market Share by Regions in 2019
Figure 59. APAC Oncology Drugs Consumption Market Share by Type in 2019
Figure 60. APAC Oncology Drugs Consumption Market Share by Application in 2019
Figure 61. China Oncology Drugs Consumption Growth 2015-2020 (BBL)
Figure 62. China Oncology Drugs Value Growth 2015-2020 ($ Millions)
Figure 63. Japan Oncology Drugs Consumption Growth 2015-2020 (BBL)
Figure 64. Japan Oncology Drugs Value Growth 2015-2020 ($ Millions)
Figure 65. Korea Oncology Drugs Consumption Growth 2015-2020 (BBL)
Figure 66. Korea Oncology Drugs Value Growth 2015-2020 ($ Millions)
Figure 67. Southeast Asia Oncology Drugs Consumption Growth 2015-2020 (BBL)
Figure 68. Southeast Asia Oncology Drugs Value Growth 2015-2020 ($ Millions)
Figure 69. India Oncology Drugs Consumption Growth 2015-2020 (BBL)
Figure 70. India Oncology Drugs Value Growth 2015-2020 ($ Millions)
Figure 71. Australia Oncology Drugs Consumption Growth 2015-2020 (BBL)
Figure 72. Australia Oncology Drugs Value Growth 2015-2020 ($ Millions)
Figure 73. Europe Oncology Drugs Consumption Market Share by Countries in 2019
Figure 74. Europe Oncology Drugs Value Market Share by Countries in 2019
Figure 75. Europe Oncology Drugs Consumption Market Share by Type in 2019
Figure 76. Europe Oncology Drugs Consumption Market Share by Application in 2019
Figure 77. Germany Oncology Drugs Consumption Growth 2015-2020 (BBL)
Figure 78. Germany Oncology Drugs Value Growth 2015-2020 ($ Millions)
Figure 79. France Oncology Drugs Consumption Growth 2015-2020 (BBL)
Figure 80. France Oncology Drugs Value Growth 2015-2020 ($ Millions)
Figure 81. UK Oncology Drugs Consumption Growth 2015-2020 (BBL)
Figure 82. UK Oncology Drugs Value Growth 2015-2020 ($ Millions)
Figure 83. Italy Oncology Drugs Consumption Growth 2015-2020 (BBL)
Figure 84. Italy Oncology Drugs Value Growth 2015-2020 ($ Millions)
Figure 85. Russia Oncology Drugs Consumption Growth 2015-2020 (BBL)
Figure 86. Russia Oncology Drugs Value Growth 2015-2020 ($ Millions)
Figure 87. Spain Oncology Drugs Consumption Growth 2015-2020 (BBL)
Figure 88. Spain Oncology Drugs Value Growth 2015-2020 ($ Millions)
Figure 89. Middle East & Africa Oncology Drugs Consumption Market Share by Countries in 2019
Figure 90. Middle East & Africa Oncology Drugs Value Market Share by Countries in 2019
Figure 91. Middle East & Africa Oncology Drugs Consumption Market Share by Type in 2019
Figure 92. Middle East & Africa Oncology Drugs Consumption Market Share by Application in 2019
Figure 93. Egypt Oncology Drugs Consumption Growth 2015-2020 (BBL)
Figure 94. Egypt Oncology Drugs Value Growth 2015-2020 ($ Millions)
Figure 95. South Africa Oncology Drugs Consumption Growth 2015-2020 (BBL)
Figure 96. South Africa Oncology Drugs Value Growth 2015-2020 ($ Millions)
Figure 97. Israel Oncology Drugs Consumption Growth 2015-2020 (BBL)
Figure 98. Israel Oncology Drugs Value Growth 2015-2020 ($ Millions)
Figure 99. Turkey Oncology Drugs Consumption Growth 2015-2020 (BBL)
Figure 100. Turkey Oncology Drugs Value Growth 2015-2020 ($ Millions)
Figure 101. GCC Countries Oncology Drugs Consumption Growth 2015-2020 (BBL)
Figure 102. GCC Countries Oncology Drugs Value Growth 2015-2020 ($ Millions)
Figure 103. Global Oncology Drugs Consumption Growth Rate Forecast (2021-2025) (BBL)
Figure 104. Global Oncology Drugs Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 105. Americas Oncology Drugs Consumption 2021-2025 (BBL)
Figure 106. Americas Oncology Drugs Value 2021-2025 ($ Millions)
Figure 107. APAC Oncology Drugs Consumption 2021-2025 (BBL)
Figure 108. APAC Oncology Drugs Value 2021-2025 ($ Millions)
Figure 109. Europe Oncology Drugs Consumption 2021-2025 (BBL)
Figure 110. Europe Oncology Drugs Value 2021-2025 ($ Millions)
Figure 111. Middle East & Africa Oncology Drugs Consumption 2021-2025 (BBL)
Figure 112. Middle East & Africa Oncology Drugs Value 2021-2025 ($ Millions)
Figure 113. United States Oncology Drugs Consumption 2021-2025 (BBL)
Figure 114. United States Oncology Drugs Value 2021-2025 ($ Millions)
Figure 115. Canada Oncology Drugs Consumption 2021-2025 (BBL)
Figure 116. Canada Oncology Drugs Value 2021-2025 ($ Millions)
Figure 117. Mexico Oncology Drugs Consumption 2021-2025 (BBL)
Figure 118. Mexico Oncology Drugs Value 2021-2025 ($ Millions)
Figure 119. Brazil Oncology Drugs Consumption 2021-2025 (BBL)
Figure 120. Brazil Oncology Drugs Value 2021-2025 ($ Millions)
Figure 121. China Oncology Drugs Consumption 2021-2025 (BBL)
Figure 122. China Oncology Drugs Value 2021-2025 ($ Millions)
Figure 123. Japan Oncology Drugs Consumption 2021-2025 (BBL)
Figure 124. Japan Oncology Drugs Value 2021-2025 ($ Millions)
Figure 125. Korea Oncology Drugs Consumption 2021-2025 (BBL)
Figure 126. Korea Oncology Drugs Value 2021-2025 ($ Millions)
Figure 127. Southeast Asia Oncology Drugs Consumption 2021-2025 (BBL)
Figure 128. Southeast Asia Oncology Drugs Value 2021-2025 ($ Millions)
Figure 129. India Oncology Drugs Consumption 2021-2025 (BBL)
Figure 130. India Oncology Drugs Value 2021-2025 ($ Millions)
Figure 131. Australia Oncology Drugs Consumption 2021-2025 (BBL)
Figure 132. Australia Oncology Drugs Value 2021-2025 ($ Millions)
Figure 133. Germany Oncology Drugs Consumption 2021-2025 (BBL)
Figure 134. Germany Oncology Drugs Value 2021-2025 ($ Millions)
Figure 135. France Oncology Drugs Consumption 2021-2025 (BBL)
Figure 136. France Oncology Drugs Value 2021-2025 ($ Millions)
Figure 137. UK Oncology Drugs Consumption 2021-2025 (BBL)
Figure 138. UK Oncology Drugs Value 2021-2025 ($ Millions)
Figure 139. Italy Oncology Drugs Consumption 2021-2025 (BBL)
Figure 140. Italy Oncology Drugs Value 2021-2025 ($ Millions)
Figure 141. Russia Oncology Drugs Consumption 2021-2025 (BBL)
Figure 142. Russia Oncology Drugs Value 2021-2025 ($ Millions)
Figure 143. Spain Oncology Drugs Consumption 2021-2025 (BBL)
Figure 144. Spain Oncology Drugs Value 2021-2025 ($ Millions)
Figure 145. Egypt Oncology Drugs Consumption 2021-2025 (BBL)
Figure 146. Egypt Oncology Drugs Value 2021-2025 ($ Millions)
Figure 147. South Africa Oncology Drugs Consumption 2021-2025 (BBL)
Figure 148. South Africa Oncology Drugs Value 2021-2025 ($ Millions)
Figure 149. Israel Oncology Drugs Consumption 2021-2025 (BBL)
Figure 150. Israel Oncology Drugs Value 2021-2025 ($ Millions)
Figure 151. Turkey Oncology Drugs Consumption 2021-2025 (BBL)
Figure 152. Turkey Oncology Drugs Value 2021-2025 ($ Millions)
Figure 153. GCC Countries Oncology Drugs Consumption 2021-2025 (BBL)
Figure 154. GCC Countries Oncology Drugs Value 2021-2025 ($ Millions)
Figure 155. Roche Oncology Drugs Market Share (2018-2020)
Figure 156. Lunan Oncology Drugs Market Share (2018-2020)
Figure 157. HENGRUI Oncology Drugs Market Share (2018-2020)
Figure 158. QILU Oncology Drugs Market Share (2018-2020)
Figure 159. Sanofi Oncology Drugs Market Share (2018-2020)
Figure 160. AstraZeneca Oncology Drugs Market Share (2018-2020)
Figure 161. Novartis Oncology Drugs Market Share (2018-2020)
Figure 162. HANSOH Oncology Drugs Market Share (2018-2020)
Figure 163. GuiZhou YiBai Oncology Drugs Market Share (2018-2020)
Figure 164. LUYE Oncology Drugs Market Share (2018-2020)
Figure 165. Eli Lilly and Company Oncology Drugs Market Share (2018-2020)